Discovery in Our Labs
The Winthrop P. Rockefeller Cancer Institute directs cancer research for the University of Arkansas for Medical Sciences (UAMS) and its affiliated institutions. Cancer Institute scientists are committed to reducing cancer incidence, mortality and morbidity in Arkansas and the surrounding region.
The Cancer Institute accomplishes its goals through focused research programs, shared resources and multidisciplinary disease-specific committees.
The Cancer Institute’s approach is simple: Discovery in our labs leads to the development of new treatment strategies, which are then delivered to the patients in our clinics. The bottom line for our patients is that our research fuels innovative treatment options.Our Research
Research Programs
All research at the Cancer Institute is organized into four distinct research programs to maximize and nurture scientific collaborations and productivity.
Learn More
Clinical Research
Clinical research conducted at the Cancer Institute focuses on cancer prevention, screening, treatment and support.
Learn More
Shared Resources
Shared resources provide Cancer Institute members with cost-effective access to specialized technologies, methodologies and quality control.
Learn More
Education
Numerous educational and training opportunities are available for cancer researchers from the Cancer Institute, the Translational Research Institute and UAMS Research Administrati
Learn More
Internal Funding
Internal funds available to support cancer research are updated monthly.
Learn More
Membership
The mission of the Winthrop P. Rockefeller Cancer Institute is to translate today’s discoveries into tomorrow’s strategies to effectively reduce cancer throughout its continuum fr
Learn MoreResearch: UAMS Cancer Institute Joins KIYATEC Clinical Study of Test to Predict Pre-Treatment, Patient-Specific Response to Ovarian Cancer Drugs
KIYATEC, Inc. today announced that the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has joined the growing roster of institutions participating in its 3D-PREDICT clinical study to validate the company’s test as a patient-specific predictor of response to recommended drug therapies for patients with ovarian cancer.
More News
UAMS Part of International Effort to Build AI Platform for Cancer Research
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) will have a key role in a major international effort using artificial intelligence (AI) to teach computers at local research centers how to recognize cancer. UAMS has received a four-year grant of $894,074 as part of EuCanImage, a nearly $9 million cancer research project…
Read more
Findings on DNA Damage Repair Published by UAMS Cancer Researcher
A research team led by cancer researcher Justin Leung, Ph.D., at the University of Arkansas for Medical Sciences (UAMS) has uncovered the role of the protein RNF168 in DNA damage repair and shown how mutations of the protein affect people with a rare genetic condition.
Read more
UAMS Radiation Oncologist Awarded $1.86 Million National Cancer Institute Grant
A five-year grant of more than $1.86 million from the National Cancer Institute (NCI) to the University of Arkansas for Medical Sciences (UAMS) will fund research aimed at reducing long-term neurological damage caused by a common cancer treatment regimen.
Read more
Proteomics Symposium Draws Leaders from Across the Country
To conduct biomedical research, scientists must be able to identify, analyze and compare proteins in biological samples. This complex process requires facilities – known as proteomics cores – that house the specialized equipment and highly trained staff required for such a task.
Read moreWant to read more stories like these?